Collagen Crosslinking
Corneal collagen cross-linking riboflavin therapy is a relatively new experimental treatment for KC. The process works by strengthening the collagen fibers which provide the structural integrity of the cornea. The treatment consists of applying riboflavin (vitamin B2) eyedrops to the corneas and then exposing them to ultraviolet light to activate the riboflavin, allowing it to bind to the collagen in the cornea. Although it is a relatively new procedure and still being investigated, the hope is that the process will halt the progression of keratoconus.













